Ascend Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ascend Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ascend Trial Today - Breaking & Trending Today

Acalabrutinib and Zanubrutinib Produce Similar PFS in a Matching-Adjusted Indirect Comparison in R/R CLL

Published: June 8, 2023

Acalabrutinib and zanubrutinib demonstrated similar investigator-assessed progression-free survival in patients with relapsed/refractory chronic lymphocytic leukemia.

Source: onclive.com

Related Topics:

Acalabrutinib CalquenceAcalabrutinib And ZanubrutinibPatients With Relapsed Refractory Chronic Lymphocytic LeukemiaAscend TrialAlpine Trial